A digital intake tool to avert outpatient visits in a FIT-based colorectal cancer screening population: study protocol of a multicentre, prospective non-randomized trial - the DIT-trial.

Colonoscopy Colorectal cancer screening Counselling Patient education Telemedicine

Journal

BMC gastroenterology
ISSN: 1471-230X
Titre abrégé: BMC Gastroenterol
Pays: England
ID NLM: 100968547

Informations de publication

Date de publication:
18 Jan 2024
Historique:
received: 18 09 2023
accepted: 07 11 2023
medline: 19 1 2024
pubmed: 19 1 2024
entrez: 18 1 2024
Statut: epublish

Résumé

Currently all participants of the Dutch colorectal cancer (CRC) screening program with a positive faecal immunochemical test (FIT) are seen at the outpatient clinic to assess their health status, receive information on colonoscopy and CRC risk, and provide informed consent. However, for many patients this information could probably also safely be exchanged in an online setting, in order to reduce the burden for patients, healthcare system, and environment. In this study we will evaluate if a face-to-face pre-colonoscopy consultation can be replaced by a Digital Intake Tool (DIT) in a CRC screening population. This is a prospective multicentre single-arm, non-randomized study with a non-inferiority design. The DIT will triage a total of 1000 participants and inform them about CRC risk, colonoscopy, sedation, and provide bowel preparation instructions. Participants identified as high-risk (i.e., red-triaged) will be contacted by phone or scheduled for an appointment at the outpatient clinic. The primary outcome measure will be adequate bowel preparation rate, defined as the proportion of participants with a Boston Bowel Preparation (BBPS) score ≥ 6. To compare our primary outcome, we will use colonoscopy data from 1000 FIT positive participants who visited the outpatient clinic for pre-colonoscopy consultation. Secondary outcomes will include participation rate, colonoscopy adherence rate, patient experience in terms of satisfaction and anxiety, knowledge transfer, number of outpatient visits that can be averted by the DIT, and cost-effectiveness of the tool. Ethical approval was obtained from the Medical Ethical Committee of the Erasmus Medical Center (MEC-2021-0098). This study aims to assess if a face-to-face pre-colonoscopy consultation can be replaced by an eHealth assessment and education tool in a FIT-based CRC screening program. In case favourable results are established, the intervention evaluated in this study could significantly impact CRC screening programs, benefiting both patients and healthcare systems on a (inter)national scale. Additionally, it would enable more personalized care as the DIT can be easily customized and made feasible in other languages, thereby enhancing healthcare accessibility. Dutch Trial Register: NL9315 , date of registration: March 8th, 2021.

Sections du résumé

BACKGROUND BACKGROUND
Currently all participants of the Dutch colorectal cancer (CRC) screening program with a positive faecal immunochemical test (FIT) are seen at the outpatient clinic to assess their health status, receive information on colonoscopy and CRC risk, and provide informed consent. However, for many patients this information could probably also safely be exchanged in an online setting, in order to reduce the burden for patients, healthcare system, and environment. In this study we will evaluate if a face-to-face pre-colonoscopy consultation can be replaced by a Digital Intake Tool (DIT) in a CRC screening population.
METHODS METHODS
This is a prospective multicentre single-arm, non-randomized study with a non-inferiority design. The DIT will triage a total of 1000 participants and inform them about CRC risk, colonoscopy, sedation, and provide bowel preparation instructions. Participants identified as high-risk (i.e., red-triaged) will be contacted by phone or scheduled for an appointment at the outpatient clinic. The primary outcome measure will be adequate bowel preparation rate, defined as the proportion of participants with a Boston Bowel Preparation (BBPS) score ≥ 6. To compare our primary outcome, we will use colonoscopy data from 1000 FIT positive participants who visited the outpatient clinic for pre-colonoscopy consultation. Secondary outcomes will include participation rate, colonoscopy adherence rate, patient experience in terms of satisfaction and anxiety, knowledge transfer, number of outpatient visits that can be averted by the DIT, and cost-effectiveness of the tool. Ethical approval was obtained from the Medical Ethical Committee of the Erasmus Medical Center (MEC-2021-0098).
DISCUSSION CONCLUSIONS
This study aims to assess if a face-to-face pre-colonoscopy consultation can be replaced by an eHealth assessment and education tool in a FIT-based CRC screening program. In case favourable results are established, the intervention evaluated in this study could significantly impact CRC screening programs, benefiting both patients and healthcare systems on a (inter)national scale. Additionally, it would enable more personalized care as the DIT can be easily customized and made feasible in other languages, thereby enhancing healthcare accessibility.
TRIAL REGISTRATION BACKGROUND
Dutch Trial Register: NL9315 , date of registration: March 8th, 2021.

Identifiants

pubmed: 38238726
doi: 10.1186/s12876-023-03039-0
pii: 10.1186/s12876-023-03039-0
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

38

Informations de copyright

© 2024. The Author(s).

Références

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.
pubmed: 33538338 doi: 10.3322/caac.21660
Lauby-Secretan B, Vilahur N, Bianchini F, Guha N, Straif K. International Agency for Research on Cancer handbook working G. The IARC perspective on colorectal Cancer screening. N Engl J Med. 2018;378(18):1734–40.
pubmed: 29580179 pmcid: 6709879 doi: 10.1056/NEJMsr1714643
Cardoso R, Guo F, Heisser T, Hoffmeister M, Brenner H. Utilisation of colorectal Cancer screening tests in European countries by type of screening offer: results from the European health interview survey. Cancers (Basel). 2020;12(6)
Hassan C, East J, Radaelli F, Spada C, Benamouzig R, Bisschops R, et al. Bowel preparation for colonoscopy: European Society of Gastrointestinal Endoscopy (ESGE) guideline - update 2019. Endoscopy. 2019;51(8):775–94.
pubmed: 31295746 doi: 10.1055/a-0959-0505
Li P, He X, Yang X, Du J, Wu W, Tu J. Patient education by smartphones for bowel preparation before colonoscopy. J Gastroenterol Hepatol. 2022;37(7):1349–59.
pubmed: 35384043 doi: 10.1111/jgh.15849
Veldhuijzen G, Klemt-Kropp M, Noomen C, Van Esch AA, Tjwa ET, Drenth J. Computer-assisted instruction before colonoscopy is as effective as nurse counselling, a clinical pilot trial. Endosc Int Open. 2017;5(8):E792–E7.
pubmed: 28791330 pmcid: 5546893 doi: 10.1055/s-0043-110813
Shaw MJ, Beebe TJ, Tomshine PA, Adlis SA, Cass OW. A randomized, controlled trial of interactive, multimedia software for patient colonoscopy education. J Clin Gastroenterol. 2001;32(2):142–7.
pubmed: 11205650 doi: 10.1097/00004836-200102000-00010
Park JS, Kim MS, Kim H, Kim SI, Shin CH, Lee HJ, et al. A randomized controlled trial of an educational video to improve quality of bowel preparation for colonoscopy. BMC Gastroenterol. 2016;16(1):64.
pubmed: 27317249 pmcid: 4912707 doi: 10.1186/s12876-016-0476-6
Stoop EM, de Wijkerslooth TR, Bossuyt PM, Stoker J, Fockens P, Kuipers EJ, et al. Face-to-face vs telephone pre-colonoscopy consultation in colorectal cancer screening; a randomised trial. Br J Cancer. 2012;107(7):1051–8.
pubmed: 22918392 pmcid: 3461154 doi: 10.1038/bjc.2012.358
Veldhuijzen G, Klemt-Kropp M, Terhaar Sive Droste JS, van Balkom B, van Esch AAJ, Drenth JPH. Computer-based patient education is non-inferior to nurse counselling prior to colonoscopy: a multicenter randomized controlled trial. Endoscopy. 2021;53(3):254–63.
pubmed: 32702759 doi: 10.1055/a-1225-8708
The National Institute for Public Health and the Environment (RIVM). Framework for the Execution of the Dutch Colorectal Cancer Screening Programme, 2021. Available from: https://www.rivm.nl/documenten/framework-execution-dutch-crc-screening-2021-0 . Accessed Dec 2020.
The National Institute for Public Health and the Environment (RIVM). National Monitoring of the Colorectal Cancer Screening Programme in the Netherlands, 2021. Available from: https://www.rivm.nl/en/documenten/monitor-colorectal-cancer-2021 . Accessed 4 Oct 2022.
Denters MJ, Deutekom M, Essink-Bot ML, Bossuyt PM, Fockens P, Dekker E. Assessing knowledge and attitudes towards screening among users of Faecal immunochemical test (FIT). Health Expect. 2015;18(5):839–49.
pubmed: 23432931 doi: 10.1111/hex.12056
The National Institute for Public Health and the Environment (RIVM). Meedoen aan bevolkingsonderzoeken en screeningen. Available from: https://www.rivm.nl/bevolkingsonderzoeken-en-screeningen/meedoen .
Marteau TM, Bekker H. The development of a six-item short-form of the state scale of the Spielberger state-trait anxiety inventory (STAI). Br J Clin Psychol. 1992;31(3):301–6.
pubmed: 1393159 doi: 10.1111/j.2044-8260.1992.tb00997.x
Moss S, Ancelle-Park R, Brenner H. International Agency for Research on C. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition--Evaluation and interpretation of screening outcomes. Endoscopy. 2012;44(Suppl 3):SE49–64.
pubmed: 23012122
Gingold-Belfer R, Leibovitzh H, Boltin D, Issa N, Tsadok Perets T, Dickman R, et al. The compliance rate for the second diagnostic evaluation after a positive fecal occult blood test: a systematic review and meta-analysis. United Europ Gastroenterol J. 2019;7(3):424–48.
doi: 10.1177/2050640619828185
Etzioni DA, Yano EM, Rubenstein LV, Lee ML, Ko CY, Brook RH, et al. Measuring the quality of colorectal cancer screening: the importance of follow-up. Dis Colon Rectum. 2006;49(7):1002–10.
pubmed: 16673056 doi: 10.1007/s10350-006-0533-2
Morris S, Baio G, Kendall E, von Wagner C, Wardle J, Atkin W, et al. Socioeconomic variation in uptake of colonoscopy following a positive faecal occult blood test result: a retrospective analysis of the NHS bowel Cancer screening Programme. Br J Cancer. 2012;107(5):765–71.
pubmed: 22864455 pmcid: 3425978 doi: 10.1038/bjc.2012.303
Bie AKL, Brodersen J. Why do some participants in colorectal cancer screening choose not to undergo colonoscopy following a positive test result? A qualitative study. Scand J Prim Health Care. 2018;36(3):262–71.
pubmed: 30238859 pmcid: 6381546 doi: 10.1080/02813432.2018.1487520
Llovet D, Serenity M, Conn LG, Bravo CA, McCurdy BR, Dubé C, et al. Reasons for lack of follow-up colonoscopy among persons with a positive fecal occult blood test result: a qualitative study. Am J Gastroenterol. 2018;113(12):1872–80.
pubmed: 30361625 pmcid: 6768592 doi: 10.1038/s41395-018-0381-4
Woudstra AJ, Dekker E, Essink-Bot ML, Suurmond J. Knowledge, attitudes and beliefs regarding colorectal cancer screening among ethnic minority groups in the Netherlands - a qualitative study. Health Expect. 2016;19(6):1312–23.
pubmed: 26576015 doi: 10.1111/hex.12428
Meppelink CS, van Weert JC, Haven CJ, Smit EG. The effectiveness of health animations in audiences with different health literacy levels: an experimental study. J Med Internet Res. 2015;17(1):e11.
pubmed: 25586711 pmcid: 4319081 doi: 10.2196/jmir.3979
Deutekom M, van Rijn AF, Dekker E, Blaauwgeers H, Stronks K, Fockens P, et al. Uptake of faecal occult blood test colorectal cancer screening by different ethnic groups in the Netherlands. Eur J Pub Health. 2009;19(4):400–2.
doi: 10.1093/eurpub/ckp051
Genoff MC, Zaballa A, Gany F, Gonzalez J, Ramirez J, Jewell ST, et al. Navigating language barriers: a systematic review of patient Navigators' impact on Cancer screening for limited English proficient patients. J Gen Intern Med. 2016;31(4):426–34.
pubmed: 26786875 pmcid: 4803699 doi: 10.1007/s11606-015-3572-3

Auteurs

Fleur E Marijnissen (FE)

Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Center, Rotterdam, the Netherlands.

Pieter J F de Jonge (PJF)

Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Center, Rotterdam, the Netherlands.

Nicole S Erler (NS)

Department of Biostatistics, Erasmus MC, University Medical Center, Rotterdam, the Netherlands.
Department of Epidemiology, Erasmus MC, University Medical Center, Rotterdam, the Netherlands.

Sohal Y Ismail (SY)

Department of Psychiatry, Section Medical Psychology and Psychotherapy, Erasmus MC, University Medical Center, Rotterdam, the Netherlands.

Iris Lansdorp-Vogelaar (I)

Department of Public Health, Erasmus MC, University Medical Center, Rotterdam, the Netherlands.

Manon C W Spaander (MCW)

Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Center, Rotterdam, the Netherlands. v.spaander@erasmusmc.nl.

Classifications MeSH